Segment Wealth Management, LLC Abb Vie Inc. Transaction History

Segment Wealth Management, LLC

$1.41 Billion
Q3 2024

A detailed history of Segment Wealth Management, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Segment Wealth Management, LLC holds 6,047 shares of ABBV stock, worth $1.08 Million. This represents 0.08% of its overall portfolio holdings.

Number of Shares

6,047

Previous 6,055 0.13%

Holding current value

$1.08 Million

Previous $1.04 Million 15.03%

% of portfolio

0.08%

Previous 0.08%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 22, 2024	SELL	$163.84 - $199.33 $1,310 - $1,594	-8 Reduced 0.13%	6,047 $1.19 Million
Q2 2024 Jul 22, 2024	BUY	$154.79 - $180.76 $107,733 - $125,808	696 Added 12.99%	6,055 $1.04 Million
Q1 2024 Apr 24, 2024	BUY	$159.82 - $182.1 $23,333 - $26,586	146 Added 2.8%	5,359 $975,000
Q4 2023 Jan 25, 2024	BUY	$137.6 - $154.97 $187,686 - $211,379	1,364 Added 35.44%	5,213 $807,000
Q3 2023 Oct 24, 2023	SELL	$133.59 - $154.65 $110,746 - $128,204	-829 Reduced 17.72%	3,849 $573,000
Q2 2023 Jul 21, 2023	SELL	$132.51 - $164.9 $222,484 - $276,867	-1,679 Reduced 26.41%	4,678 $630,000
Q4 2022 Jan 13, 2023	SELL	$138.31 - $165.87 $10,373 - $12,440	-75 Reduced 1.17%	6,357 $0
Q3 2022 Oct 24, 2022	SELL	$134.21 - $153.93 $50,328 - $57,723	-375 Reduced 5.51%	6,432 $863,000
Q2 2022 Jul 20, 2022	SELL	$137.62 - $174.96 $347,765 - $442,123	-2,527 Reduced 27.07%	6,807 $1.04 Million
Q1 2022 Apr 25, 2022	BUY	$131.98 - $163.75 $13,989 - $17,357	106 Added 1.15%	9,334 $1.51 Million
Q4 2021 Jan 24, 2022	BUY	$107.43 - $135.93 $271,260 - $343,223	2,525 Added 37.67%	9,228 $1.25 Million
Q3 2021 Oct 19, 2021	BUY	$106.4 - $120.78 $2,660 - $3,019	25 Added 0.37%	6,703 $723,000
Q2 2021 Jul 20, 2021	BUY	$105.21 - $117.21 $10,521 - $11,721	100 Added 1.52%	6,678 $752,000
Q1 2021 May 10, 2021	BUY	$102.3 - $112.62 $7,979 - $8,784	78 Added 1.2%	6,578 $712,000
Q2 2020 Jul 15, 2020	SELL	$73.37 - $98.18 $11,592 - $15,512	-158 Reduced 2.37%	6,500 $638,000
Q1 2020 Apr 24, 2020	SELL	$64.5 - $97.79 $82,108 - $124,486	-1,273 Reduced 16.05%	6,658 $507,000
Q4 2019 Jan 23, 2020	BUY	$72.13 - $90.25 $107,257 - $134,201	1,487 Added 23.08%	7,931 $703,000
Q3 2019 Oct 22, 2019	SELL	$62.98 - $75.72 $9,447 - $11,358	-150 Reduced 2.27%	6,444 $488,000
Q1 2019 Apr 30, 2019	BUY	$77.14 - $90.79 $28,927 - $34,046	375 Added 6.03%	6,594 $531,000
Q4 2018 Jan 31, 2019	SELL	$77.85 - $96.01 $163,874 - $202,101	-2,105 Reduced 25.29%	6,219 $573,000
Q3 2018 Nov 07, 2018	BUY	$88.91 - $98.84 $800 - $889	9 Added 0.11%	8,324 $788,000
Q2 2018 Jul 17, 2018	SELL	$89.78 - $106.23 $2,064 - $2,443	-23 Reduced 0.28%	8,315 $770,000
Q1 2018 Apr 30, 2018	SELL	$92.01 - $123.21 $10,949 - $14,661	-119 Reduced 1.41%	8,338 $790,000
Q4 2017 Jan 23, 2018	BUY	$89.56 - $98.21 $23,464 - $25,731	262 Added 3.2%	8,457 $818,000
Q3 2017 Oct 26, 2017	SELL	$69.85 - $89.22 $9,499 - $12,133	-136 Reduced 1.63%	8,195 $728,000
Q2 2017 Aug 11, 2017	BUY	N/A	8,331	8,331 $604,000

Others Institutions Holding ABBV

# of Institutions

3,853

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $317B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Segment Wealth Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Segment Wealth Management, LLC with notifications on news.

Account

Segment Wealth Management, LLC Abb Vie Inc. Transaction History